Skip to main content

Advertisement

SpringerLink
Log in

The role of HDL-related myeloperoxidase (MPO) and paraoxonase 1 (PON1) in terms of coronary artery disease in Hashimoto’s thyroiditis

  • Original Article
  • Published:
Comparative Clinical Pathology Aims and scope Submit manuscript

Abstract

Hashimoto’s thyroiditis (HT) is an autoimmune disease of the thyroid gland. Free radicals have been reported to be responsible for the complications observed in the pathogenesis of thyroid diseases and the later stages of the disease. Myeloperoxidase (MPO), which is released from neutrophils during inflammation and oxidative stress and causes cell destruction, is a marker that plays a role in the development of cardiovascular disease associated with oxidative damage in the arterial wall. Paraoxonase-1(PON-1), which is one of the molecules that play a role in oxidant balance, is an enzyme that inhibits lipoprotein oxidation by hydrolyzing lipid peroxides in oxidized low-density lipoprotein(LDL) structure. We investigated the role of HDL-associated MPO and PON-1 in patients with HT in terms of coronary artery disease. Our study group consisted of 54 patients with Hashimoto’s diagnosis and 50 healthy individuals in the control group.MPO and PON-1 levels were determined spectrophotometrically. When the study groups were evaluated, MPO levels were significantly higher in patients with Hashimoto thyroiditis than in the control group (p < 0.05, p = 0.001). A negative correlation was obtained between MPO and PON-1 (r =  − 0.685). The decrease in PON-1 activity and increase in MPO activity due to the hypothyroid effect increases lipid peroxide formation and accelerates oxidized LDL formation, which leads to a decrease in antioxidant capacity and the development of atherosclerosis. Since oxidative stress in thyroid diseases is also responsible for the complications observed in the later stages of the disease, we think that important data were obtained with this study in terms of both diagnosis and treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  • Aldridge WN (1953) Serum esterases. I. Two types of esterase (A and B) hydrolysing p-nitrophenyl acetate, propionate and butyrate, and a method for their determination. Biochem J 53(1):110–7

  • Baser H, Can U, Baser S, Yerlikaya FH, Aslan U, Hidayetoglu BT (2015) Assesment of oxidative status and its association with thyroid autoantibodies in patients with euthyroid autoimmune thyroiditis. Endocrine 48(3):916–923

    Article  CAS  PubMed  Google Scholar 

  • Baskol G, Atmaca H, Tanriverdi F, Baskol M, Kocer D, Bayram F (2007) Oxidative stress and enzymatic antioxidant status in patients with hypothyroidism before and after treatment. Exp Clin Endocrinol Diabetes 115(8):522–526

    Article  CAS  PubMed  Google Scholar 

  • Brown MS, Goldstein JL (1992) Koch’s postulates for cholesterol. Cell 71(2):187

    Article  CAS  PubMed  Google Scholar 

  • Cebeci E, Oner FA, Usta M, Yurdakul S, Erguney M (2011) Evaluation of oxidative stress, the activities of paraoxonase and arylesterase in patients with subclinic hypothyroidism. Acta Biomed 82(3):214–222

    PubMed  Google Scholar 

  • Cheng D, Talib J, Stanley CP, Rashid I, Michaëlsson E, Lindstedt EL et al (2019) Inhibition of MPO (myeloperoxidase) attenuates endothelial dysfunction in mouse models of vascular ınflammation and atherosclerosis. Arterioscler Thromb Vasc Biol 39(7):1448–1457

    Article  CAS  PubMed  Google Scholar 

  • Fenton HJJ (1984) Oxidation of tartaric acid in presence of iron. J Chem Soc 65:899–910

    Article  Google Scholar 

  • Goldstein JL, Ho YK, Basu SK, Brown MS (1979) Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc Natl Acad Sci USA 76(1):333–337

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Gomaraschi M, Calabresi L, Franceschini G (2016) Protective effects of HDL against ıschemia/reperfusion ınjury. Front Pharmacol 25(7):2

    Google Scholar 

  • Kato Y (2016) Neutrophil myeloperoxidase and its substrates: formation of specific markers and reactive compounds during inflammation. J Clin Biochem Nutr 58(2):99–104

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Khan AA, Alsahli MA, Rahmani AH (2018) Myeloperoxidase as an active disease biomarker: recent biochemical and pathological perspectives. Med Sci (basel) 6(2):33

    PubMed  Google Scholar 

  • Klebanoff SJ, Clark FA (1978) The neutrophil: function and clinical disorders, 1. Elsevier/North Holland Biomedical Press, Amsterdam, The Netherlands, p 810

    Google Scholar 

  • Klebanoff SJ, Rosen H (1978) The role of myeloperoxidase in the microbicidal activity of polymorphonuclear leukocytes. Ciba Found Symp 6–8;(65):263–84

  • Koç HB, Kaçar Y (2012) Paraoksonaz1 (Pon1) Enzimi ve Polimorfizmleri. Arşiv Kaynak Tarama Dergisi 21(1):27–41

    Google Scholar 

  • Kosmas CE, Martinez I, Sourlas A, Bouza KV, Campos FN, Torres V et al (2018) High-density lipoprotein (HDL) functionality and its relevance to atherosclerotic cardiovascular disease. Drugs Context 28(7):212525

    Google Scholar 

  • Mackness B, Mackness M (2019) Unexpectedly higher diazoxon hydrolysis by serum paraoxonase-1 in coronary heart disease. Clin Biochem 65:21–23

    Article  CAS  PubMed  Google Scholar 

  • Mehanathan PB, Erusan RR, Shantaraman K, Kannan SM (2019) Antithyroid peroxidase antibodies in multinodular Hashimoto’s thyroiditis ındicate a variant etiology. J Thyroid Res 21(2019):4892329

    Google Scholar 

  • Podrez EA (2010) Anti-oxidant properties of high-density lipoprotein and atherosclerosis. Clin Exp Pharmacol Physiol 37(7):719–725

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Poncin S, Van Eeckoudt S, Humblet K, Colin IM, Gérard AC (2010) Oxidative stress: a required condition for thyroid cell proliferation. Am J Pathol 176(3):1355–1363

    Article  PubMed  PubMed Central  Google Scholar 

  • Ross R (1999) Atherosclerosis–an inflammatory disease. N Engl J Med 340(2):115–126

    Article  CAS  PubMed  Google Scholar 

  • Rossi ED, Adeniran AJ, Faquin WC (2019) Pitfalls in thyroid cytopathology. Surg Pathol Clin 12(4):865–881

    Article  PubMed  PubMed Central  Google Scholar 

  • Ruggeri RM, Vicchio TM, Cristani M, Certo R, Caccamo D, Alibrandi A et al (2016) Oxidative stress and advanced glycation end products in Hashimoto’s thyroiditis. Thyroid 26(4):504–511

    Article  CAS  PubMed  Google Scholar 

  • Sies H (1997) Oxidative stress: oxidants and antioxidants. Exp Physiol 82(2):291–295

    Article  CAS  PubMed  Google Scholar 

  • Tashian R, Shaw M (1962) Inheritance of an erythrocyte acetylesterase variant in man. Am J Hum Genet 14(3):295–300

    CAS  PubMed  PubMed Central  Google Scholar 

  • Thomas T, Sreedharan S, Khadilkar UN, Deviprasad D, Kamath MP, Bhojwani KM et al (2014) Clinical, biochemical & cytomorphologic study on Hashimoto’s thyroiditis. Indian J Med Res 140(6):729–735

    PubMed  PubMed Central  Google Scholar 

  • Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M (2006) Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact 160(1):1–40

    Article  CAS  PubMed  Google Scholar 

  • Variji A, Shokri Y, Fallahpour S, Zargari M, Bagheri B, Abediankenari S, Alizadeh A, Mahrooz A (2019) The combined utility of myeloperoxidase (MPO) and paraoxonase 1 (PON1) as two important HDL-associated enzymes in coronary artery disease: which has a stronger predictive role? Atherosclerosis 280:7–13

    Article  CAS  PubMed  Google Scholar 

  • Vivekanandan-Giri A, Byun J, Pennathur S (2011) Quantitative analysis of amino acid oxidation markers by tandem mass spectrometry. Methods Enzymol 491:73–89

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wang X, Hai C (2016) Novel insights into redox system and the mechanism of redox regulation. Mol Biol Rep 43(7):607–628

    Article  CAS  PubMed  Google Scholar 

  • Yunoki K, Naruko T, Inaba M, Inoue T, Nakagawa M, Sugioka K et al (2013) Gender-specific correlation between plasma myeloperoxidase levels and serum high-density lipoprotein-associated paraoxonase-1 levels in patients with stable and unstable coronary artery disease. Atherosclerosis 231(2):308–314

    Article  CAS  PubMed  Google Scholar 

  • Zhang R, Brennan ML, Fu X, Aviles RJ, Pearce GL, Penn MS, Topol EJ, Sprecher DL, Hazen SL (2001) Association between myeloperoxidase levels and risk of coronary artery disease. JAMA 286(17):2136–2142

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Molecular Biology and Genetics, Faculty of Science and Arts, Hitit University, Corum, Türkiye

    Gizem Uncu

  2. Department of Biochemistry, Gülhane Faculty of Pharmacy, University of Health Sciences, Ankara, Türkiye

    Emre Avcı

  3. Department of Basic Medical Sciences, Gülhane Faculty of Dentistry, University of Health Sciences, Ankara, Türkiye

    Gülçin Alp Avci

  4. Department of Internal Medicine, Faculty of Medi, Hitit University, Corum, Türkiye

    Alpaslan Karabulut

  5. Department of Medical Biochemistry, Faculty of Medicine, Yüksek İhtisas University, Ankara, Türkiye

    Cumhur Bilgi

Authors
  1. Gizem Uncu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Emre Avcı
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gülçin Alp Avci
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Alpaslan Karabulut
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Cumhur Bilgi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Emre Avcı.

Ethics declarations

Funding

This study was not supported by any funding.

Conflict of interests

The authors declare no competing interests.

Ethical approval

This study was approved by the local ethics committee on the principles of the 2008 Helsinki Declaration. Written and informed consent forms were taken for each participant. Ethics committee approval was obtained from the Ethics Committee for the study (dated 28.08.2019 and numbered 2019–33).

Informed consent

Written informed consent was obtained from all individual participants included in this study.

Consent for publication

All the authors gave their informed consent prior to their inclusion in the study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Uncu, G., Avcı, E., Avci, G.A. et al. The role of HDL-related myeloperoxidase (MPO) and paraoxonase 1 (PON1) in terms of coronary artery disease in Hashimoto’s thyroiditis. Comp Clin Pathol 32, 273–279 (2023). https://doi.org/10.1007/s00580-023-03439-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00580-023-03439-4

Keywords

Search

Navigation